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summARy – We report a case of a patient with acute pancreatitis who developed serious 
heart rhythm abnormalities on three occasions, two of which were associated with administration 
of the first generation antihistamine chloropyramine, and the third one with hypomagnesemia and 
hypokalemia. Dysrhythmic events consisted of bigeminy, multifocal ventricular extrasystoles and 
torsades de pointes-like ventricular tachycardia. electrocardiographic changes in acute pancreatitis 
in the absence of previous heart disease can occur in more than half of the cases. Antihistamines are 
medications that are known to produce heart rhythm disturbances, especially the second generation 
drugs astemizole and terfenadine. This is the first report of chloropyramine causing dysrhythmia. it 
seems that acute pancreatitis patients are especially prone to heart dysrhythmia caused by different 
factors such as electrolyte disturbances and pronounced vagal tone. Acute pancreatitis may be added 
to the list of risk factors with altered ‘repolarization reserve’, predisposing to drug-induced Qt in-
terval prolongation and possible torsades de pointes occurrence.
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Introduction
it seems that acute pancreatitis patients are espe-
cially prone to heart dysrhythmia caused by different 
factors. We report a case of a patient with acute pan-
creatitis who developed serious heart rhythm abnor-
malities in the absence of previous heart disease on 
three occasions, two of which were associated with 
antihistamine administration, while the third one was 
associated with hypomagnesemia and hypokalemia. 
We discuss the possible mechanisms and review the 
literature concerning electrocardiographic changes 
in acute pancreatitis. At the same time, we recognize 
that acute pancreatitis patients may be a risk group of 
patients who can develop drug-induced Qt interval 
prolongation.
Case Report
A 45-year-old man with acute alcoholic pancrea-
titis was transferred to our university hospital after 
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the initial management in a regional hospital due to 
a severe form of acute pancreatitis. his illness started 
some 20 days before the transfer and was complicated, 
apart from peritoneal cavity abscess formation, within 
acute renal failure necessitating intermittent hemo-
dialysis on several occasions. medical history from 
regional hospital indicated that the highest creati-
nine level was 410 μmol/l, ionized calcium was with 
the reference levels, hyperglycemia was present (11.4 
mmol/l), no data on liver enzymes were available, 
initial amylase levels were five times above normal; no 
exact Ranson score was calculated in the beginning 
of the disease. At our hospital, abdominal computed 
tomography (Ct) scan was done and it showed ne-
crosis of the pancreas, liquid collections surrounding 
the pancreas, and liquid present in bursa omenta-
lis. Abscess formation was suspected and explorative 
laparotomy indicated. After laparotomy during which 
necrectomy and abscessotomy of bursa omentalis 
and peripancreatic tissue was performed, the patient 
was admitted to medical-surgical intensive care unit 
(iCu). postoperative monitoring, cristalloid and col-
loid infusion were continued. Through ‘feeding’ je-
junostomy about 24 hours after surgery, enteral nutri-
tion was started along with parenteral nutrition. After 
the first 24 hours, the patient’s ApAChe ii score was 
18. Just one more hemodialysis was performed after 
the surgery since the patient’s renal function improved 
and he was in the polyuric phase of acute renal insuffi-
ciency. his creatinine levels during his iCu stay were 
below 150 μmol/l with a falling tendency. on day 5, 
the patient was ordered to receive one unit of packed 
red cells due to low hematocrit and hemoglobin levels. 
During transfusion, he developed urticaria-like exan-
thema accompanied by intense rash. transfusion was 
immediately stopped and the patient was given 120 mg 
of methylprednisolone intravenously (iv.) and the first 
generation antihistamine chloropyramine 20 mg iv. in 
the next hour, bigeminy was noted on electrocardio-
gram (eCg). During this episode of arrhythmia, the 
patient remained hemodynamically stable and with-
out symptoms. in the next few days, the exanthema 
persisted and dermatologic consultation was asked for. 
on day 9, dermatologist prescribed methylpredniso-
lone and chloropyramine. on the same day, within 
minutes after administration of chloropyramine, the 
patient developed arrhythmia, bigeminy, and ventric-
ular extrasystoles (ves), which were multifocal, in 
couplets and with R on t phenomenon (fig. 1, eCg 
1 a,b). The patient experienced nausea, dizziness and 
chest pain, although remaining hemodynamically 
stable; arterial pressure was 140/90 mm hg. During 
this episode of dysrhythmia, corrected Qt intervals 
according to Bazett’s formula were noted and were 
between 436 and 460 milliseconds. After 80 mg bo-
lus iv. lidocaine, arrhythmia was terminated. it was 
assumed that arrhythmia was caused by chloropyra-
mine, which was not perceived the first time it had 
occurred (bigeminy) on day 5 of his iCu stay after the 
same drug administration. The patient did not receive 
any other medication that could be arrhythmogenic 
on either occasion. 
on day 14 of hospitalization, the patient experi-
enced another set of arrhythmia with a similar pat-
tern, i.e. multifocal ventricular ectopic beats with R 
on t phenomenon, and even ventricular tachycardia 
(torsades de pointes-like) for a brief period of time 
(fig. 1, eCg 2). electrolyte measurement on that oc-
casion showed hypokalemia and hypomagnesemia.
Arrhythmia resolved after bolus lidocaine. lido-
caine was administered in continuous infusion for the 
next 24 hours. After this event, the patient did not 
experience arrhythmia any more. During hospitaliza-
tion in surgical iCu, the patient received potassium 
and magnesium supplementation on regular basis. on 
day 21, he was transferred to surgical department in a 
satisfactory condition.
Discussion
We report a case of a patient with acute pancreati-
tis with no previous history of heart disease, who de-
veloped eCg abnormalities on three occasions during 
his iCu stay. electrocardiographic abnormalities are 
common among patients with acute pancreatitis and 
are present in more than half of the cases1-3.  pezzilli et 
al. studied a group of 56 consecutive acute pancreatitis 
patients (all without history of heart illness) and found 
52.6% of them to have some kind of eCg changes1. 
eCg abnormalities noted were as follows: bradycar-
dia, atrial extrasystoles, changes of the t wave and/
or st segment, disturbances of intraventricular con-
duction, ventricular ectopic arrhythmia, left anterior 
hemiblock, complete left bundle branch block, A-v 
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Fig. 1. ECG 1a,b – recorded after the second administration of chloropyramine: pattern of bigeminy and VES couplets 
with R on T phenomenon; ECG 1a: pattern of bigeminy and couplets of ventricular premature beats with R on T phe-
nomenon; ECG 1b: there are two sets of couplets of VES, with a single VES in the middle. VES appear to be multifocal. 
ECG 2 – recorded on the third occasion the patient developed arrhythmia. Hypomagnesemia was noted in laboratory 
results (0.41 mmol-1). Ventricular tachycardia appears to be torsades de pointes-like.
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block of first degree, and ventricular fibrillation1,2. 
in the study by Rubio-tapia et al., the most frequent 
eCg pathological findings were nonspecific changes 
of repolarization, sinus tachycardia, and left anterior 
hemiblock3. Concerning Qt interval variation among 
patients with pancreatic disease, Ates et al. investigat-
ed a group of patients with acute biliary pancreatitis 
and found a significant prolongation of Qt interval 
compared to healthy controls4. Belval et al. have pre-
sented a case of a patient with acute pancreatitis who 
developed severe bradycardia on several occasions ne-
cessitating frequent atropine use5. All of these findings 
could be explained only partially. electrolyte distur-
bances are frequent among these patients and can be 
blamed for the occurrence of eCg pathological find-
ings. Both hypokalemia and hypomagnesemia can 
result in serious adverse effects on heart automaticity 
rhythm6. sinus tachycardia can be explained by febrile 
episode in the course of acute illness or inflammatory 
complication. in the 1950s, lieberman et al. offered a 
different kind of solution: they infused trypsin to rab-
bits, which produced marked changes in the rhythm, 
and alteration in the p, QRs, s-t and t deflections of 
the electrocardiogram7. Another explanation has been 
proposed by hodge and messer who suggest that va-
gally mediated ‘cardiobiliary reflex’ plays an important 
role. They recorded eCg during biliary surgery and 
noticed eCg changes when gallbladder and common 
bile duct were distended8.  
The eCg changes in acute pancreatitis patients 
and their possible explanation are summarized in 
table 1. 
We analyzed correlation among heart dysrhyth-
mia occurrence, serum electrolyte disturbances, and 





A-V block of the first degree
Ventricular ectopic arrhythmia
T wave and/or ST segment changes, nonspecific 
changes of repolarization
Disturbances of intraventricular conduction
Left anterior hemiblock
Complete left bundle branch block
QT segment prolongation
Ventricular fibrillation
Etiopathogenesis of ECG changes in acute 
pancreatitis
Electrolyte disturbances (hypokalemia, hypomag-
nesemia, hypocalcemia)
Cardiobiliary reflex (vagally mediated)
Trypsinemia (experimental model in rabbits)
Table 1. ECG abnormalities and etiopathogenesis of ECG 









5 3.4 ? + Bigeminy
9 3.78 ? +
Bigeminy, multifocal ventricular 
extrasystoles (ves), couplets of ves 
with R on t phenomenon
Qtc 436-460 milliseconds
14 3.25 0.41 – Bigeminy, ventricular extrasystole, ventricular tachycardia
Table 2. Correlation among heart dysrhythmia occurrence, serum electrolyte disturbances, and chloro-
pyramine administration by days of hospitalization
chloropyramine administration by days in our patient 
(table 2). 
There were three episodes of arrhythmic events in 
our acute pancreatitis patient, two of which developed 
after chloropyramine administration and the third one 
in the setting of hypomagnesemia and hypokalemia. 
on the first occasion, the patient was administered 
chloropyramine, after which he developed bigeminy 
without symptoms. This had gone unnoticed and it 
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was only after the second administration of chloropy-
ramine four days later that we suspected that chloro-
pyramine could be the cause of dysrhythmia. During 
this episode, the patient developed multifocal ves, 
with R on t phenomenon, together with the feeling 
of nausea and chest pain. in fact, antihistamines can 
prolong Qt interval and cause serious dyshrythmia9,10. 
terfenadine and astemizole, the second generation 
antihistamines, were especially known for their car-
diac toxicity that manifested by the occurrence of tor-
sades de pointes ventricular tachycardia9. Concerning 
antihistamines of the first group, cardiac toxicity is 
not a class effect and it does not occur through h1 re-
ceptor, although some first generation antihistamines 
(promethazine, brompheniramine, diphenhydramine) 
may be associated with prolonged Qt interval and 
cardiac arrhythmia when taken in large doses or over-
doses9. our patient did not receive chloropyramine 
in large doses, in fact, on both occasions arrhythmia 
occurred after a single dose administration. The cor-
rected Qt intervals (Qtc) recorded after chloropy-
ramine administration ranged between 436 and 460 
milliseconds (ms), which is only slightly prolonged 
(the reference normal corrected Qt is less than 440 
ms). Did renal insufficiency add up to the cardiotoxic 
effect of the administered chloropyramine? We think 
it is unlikely since the patient’s kidney function was 
normalizing at the time of medication administra-
tion. There are numerous groups of medication that 
can cause Qt interval prolongation, such as antipsy-
chotics (the butyrophenones haloperidol, phenothi-
azines), antiarrhythmics of the first and third group 
(sotalol), some antidepressants, some antifungals 
(ketoconazole), macrolides (erythromycin, clarithro-
mycin, azithromycin), antiemetics (ondansetron), and 
others10,11.  many of them are used in the anesthetic 
and intensive care practice. our patient was not given 
any other medication that could have prolonged Qt 
interval except for chloropyramine. 
normal repolarization of heart muscle cells repre-
sents a complex interaction among multiple compo-
nents, namely ion currents such as potassium, sodium 
and calcium currents that can be outward and inward. 
The mechanism of acquired, drug-induced Qt interval 
prolongation involves block of the rapid component of 
the repolarizing outward potassium current11-13.  This 
prolongs repolarization, is manifested by prolonga-
tion of Qt interval on eCg, and causes heart muscle 
cells to be more susceptible to early after-depolariza-
tion11,13. Qt interval prolongation longer than 500 ms 
significantly increases the risk of torsades de pointes 
ventricular tachycardia occurrence13. 
not every patient exposed to drugs that block po-
tassium current develops exaggerated Qt prolonga-
tion and arrhythmias and this is one of the reasons why 
the concept of ‘repolarization reserve’ was developed 
by Roden and Abraham12. This concept recognizes 
the complexity of repolarization and involvement of 
different ion currents in its process (potassium, so-
dium, calcium ion currents), stressing that potassium 
outward current is the most important one. As a con-
sequence of this ‘reserve’, loss of one component of re-
polarization will not lead to marked Qt interval pro-
longation. only if repolarization would be challenged 
by another superimposed event, such as administra-
tion of a drug that blocks potassium outward cur-
rent, Qt prolongation will be substantial and could 
lead to torsades de pointes12,13.  interestingly, there is a 
provocative test using sotalol to assess the stability of 
myocardial repolarization, developed by Kääb et al.14. 
Controlled exposure to sotalol, which blocks repolar-
izing outward potassium current, successfully identi-
fied patients with normal Qtc intervals but altered 
myocardial repolarization and susceptibility to exag-
gerated Qt interval prolongation. sotalol challenge 
can be used as a clinical test only in highly controlled 
environment and in specialized centers14. 
some of the conditions and risk factors for drug-
induced Qt interval prolongation and torsades de 
pointes ventricular tachycardia are female gender, 
diuretic use, bradycardia, congestive heart failure, 
hypomagnesemia, hypokalemia, digitalis use, fast iv. 
infusion of a known Qt interval prolonging medi-
cation, and others13. Acute pancreatitis patients often 
experience many of these risk factors and conditions 
in the course of their illness. They can even develop 
serious heart rhythm disturbances in the absence of 
other proarrhythmogenic factors. mofrad et al. have 
described a case of a female patient with acute pancre-
atitis who developed ventricular fibrillation on several 
occasions in a setting of prolonged Qt interval with 
no obvious explanation, necessitating insertion of an 
automatic internal cardioverter defibrillator device15. 
in the same case, cardiac dysrhythmia abated once 
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pancreatitis had been resolved. it seems that acute 
pancreatitis patients could possess altered ‘repolariza-
tion reserve’ and might experience serious arrhyth-
mia when challenged by a proarrhythmogenic factor 
such as electrolyte disturbances or proarrhythmogenic 
medication administration. We think that acute pan-
creatitis should be added to the list of risk factors for 
drug-induced Qt interval prolongation and occur-
rence of torsades de pointes ventricular tachycardia.
on the third occasion, our patient developed ma-
lignant ventricular dysrhythmia in a setting of hypo-
magnesemia (0.41 mmol/l) and hypokalemia (3.25 
mmol/l), which first started as bigeminy, then mul-
tifocal ves, and finally ventricular tachycardia (tor-
sades de pointes-like). hypomagnesemia is common 
in iCu patients, its incidence being as high as 65%16. 
serum magnesium levels below 0.7 mmol/l are as-
sociated with eCg changes indistinguishable from 
hypokalemia-related effects, including st segment 
depression, flattened t waves, and prolongation of 
pR and Qt/Qtc intervals17. Arrhythmias associated 
with serum hypomagnesemia include ventricular fi-
brillation among other possible eCg changes17. hy-
pokalemia alone does not produce serious ventricular 
cardiac arrhythmias18. When combined with other 
conditions that can promote arrhythmias such as 
magnesium depletion, digitalis, myocardial ischemia, 
it enhances the proarrhythmic effects of these other 
conditions18. it is estimated that about 40% of patients 
who are hypokalemic have associated hypomag-
nesemia, the leading cause being the use of diuretics19. 
urinary magnesium losses are most pronounced with 
the use of loop diuretics such as furosemide. it is im-
portant to stress that hypokalemia that accompanies 
magnesium depletion can be refractory to potassium 
replacement therapy as long as magnesium deficiency 
is not corrected19. 
All of arrhythmia episodes in our patient were un-
eventful owing to prompt diagnosis and immediate 
therapy. our case is unique in that it describes seri-
ous dysrhythmia in a patient with acute pancreatitis 
after medication administration. to our knowledge, 
there are no reports on serious dysrhythmia after 
chloropyramine administration, which is in use in 
some countries. Distinct time link between chloro-
pyramine administration and arrhythmia occurrence 
could be made in our case; on both occasions of chlo-
ropyramine administration, arrhythmia developed 
within minutes. The third occurrence of arrhythmia 
was due to hypomagnesemia and hypokalemia, but it 
seems that our patient was especially prone to heart 
muscle excitability and arrhythmia. unfortunately, 
we did not record magnesium levels on the days the 
patient developed arrhythmia after chloropyramine 
administration. on the first occasion of dysrhythmia 
after chloropyramine administration, the patient was 
hypokalemic (3.4 mmol/l), which must have had an 
additive effect to arrhythmia occurrence. 
There are a few points to emphasize when dealing 
with acute pancreatitis patients.
•	 ECG	abnormalities	 in	 acute	pancreatitis	 are	 fre-
quent; the etiology is debatable.
•	 Always	 beware	 of	 hypomagnesemia	 and	 hy-
pokalemia as arrhythmogenic factors, be sure 
to correct them. Remember that many patients 
who are hypokalemic, also experience hypomag-
nesemia. hypokalemia in these cases cannot be 
corrected unless magnesium supplementation is 
given.
•	 In	some	critically	ill	patients,	several	proarrhyth-
mogenic factors can occur at the same time, almost 
certainly leading to dysrhythmic events. 
•	 When	 using	 potentially	 arrhythmogenic	 drugs	
such as antihistamines, antipsychotics, macrolides 
and other in patients with acute pancreatitis, re-
member that these patients may already have chal-
lenged repolarization and exaggerated Qt pro-
longation. Continuous eCg monitoring during 
medication administration is essential.
•	 When	dealing	with	torsades	de	pointes	ventricular	
tachycardia such as the one in our case, although 
lidocaine worked, the first therapy option is mag-
nesium sulfate 2 grams iv., irrespective of the serum 
magnesium levels; potassium should be maintained 
in the high-normal range (4.5-5.0 mmol/l)20. if 
hemodynamically unstable polymorphic tachycar-
dia or ventricular fibrillation develops, nonsyn-
chronized defibrillation is indicated20. one should 
remember that class iA antiarrhythmics (disopy-
ramide, procainamide, quinidine) and class iii an-
tiarrhythmics (dofetilide, ibutilide, sotalol) should 
not be given to treat these arrhythmias, since they 
themselves can prolong Qt interval and cause tor-
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sades de pointes ventricular tachycardia. The data 
on amiodarone are conflicting, it seems that the 
risk of torsades de pointes ventricular tachycardia 
occurrence after its administration is low, although 
there are some reports that amiodarone can cause 
torsades de pointes ventricular tachycardia20,21. 
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sažetak
ponAvlJAne epizoDe ARitmiJe KoD BolesniKA s AKutnim pAnKReAtitisom – 
smAnJenJe “RepolARizACiJsKe RezeRve” KAo pAtofiziološKo oBJAšnJenJe
A. Uvelin, D. Hajduković, V. Vrsajkov, R. Kolak, A. Lazukić, S. Vicković i Z.Gojković 
prikazujemo slučaj bolesnika s akutnim pankreatitisom koji je tijekom liječenja na odjelu intenzivne terapije imao tri 
epizode aritmije, od kojih su dvije bile povezane s davanjem antihistaminika prve generacije kloropiramina, dok su na 
nastanak treće epizode aritmije uticale hipokalijemija i hipomagnezemija. tipovi aritmije kod bolesnika su bile bigemi-
nija, multifokalne ventrikulske ekstrasistole i ventrikulska tahikardija torsades de pointes. promjene u elektrokardiogramu 
kod bolesnika s akutnim pankreatitisom koji nemaju kroničnu srčanu bolest mogu se javiti u više od polovine bolesnika. 
Antihistaminici su skupina lijekova koji mogu izazvati disritmije. ovo naročito važi za antihistaminike druge generacije 
astemizol i terfenadin. Dosad u literaturi, prema našim saznanjima, nije opisan nijedan slučaj disritmije koja je uzrokovana 
davanjem kloropiramina. izgleda da su bolesnici s akutnim pankreatitisom naročito podložni nastanku disritmija uzroci 
kojih mogu bit elektrolitni poremećaji ili povišen vagusni tonus. Akutni pankreatitis bi se mogao dodati na popis rizičnih 
čimbenika za nastanak izmijenjene “repolarizacijske rezerve” kardiomiocita, koja može izazvati produljenje Qt intervala 
i ventrikulsku tahikardiju torsades de pointes.
Ključne riječi: Pankreatitis; Antihistaminici; Magnezij, manjak; Hipokalijemija; Aritmije, srčane; Torsades de pointes; Pro-
duljeni QT-interval – uzrokovan lijekovima; Prikaz slučaja
